Antimicrobial susceptibility among pathogens colle...[Antimicrob Agents Chemother. 2006]

SearchDatabase nameforSearch term

Advanced Search

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

Review: 0

Click to change filter selection through MyNCBI.

1: Antimicrob Agents Chemother. 2006 Oct;50(10):3479-84. Links

Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial.

Waites KB, Duffy LB, Dowzicky MJ.

Section of Clinical Microbiology, University of Alabama at Birmingham, Birmingham, AL 35249, USA. waites@path.uab.edu

The activities of tigecycline and comparators against isolates collected from 76 U.S. centers between January 2004 and September 2005 were assessed. Tigecycline MIC(90)s were < or =2 microg/ml for Klebsiella pneumoniae, Klebsiella oxytoca, Escherichia coli, Enterobacter aerogenes, Enterobacter cloacae, Serratia marcescens, Acinetobacter baumannii, Staphylococcus aureus, Enterococcus faecalis, Enterococcus faecium, and Streptococcus agalactiae.

PMID: 17005838 [PubMed - indexed for MEDLINE]

PMCID: PMC1610085

Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Clin Ther. 2008 Nov; 30(11):2040-50.

[Clin Ther. 2008]
Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Diagn Microbiol Infect Dis. 2005 Jul; 52(3):187-93.

[Diagn Microbiol Infect Dis. 2005]
Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Diagn Microbiol Infect Dis. 2005 Jul; 52(3):203-8.

[Diagn Microbiol Infect Dis. 2005]
ReviewTigecycline: a novel glycylcycline antibiotic.
Expert Rev Anti Infect Ther. 2006 Feb; 4(1):9-25.

[Expert Rev Anti Infect Ther. 2006]
ReviewTigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
Clin Ther. 2005 Jan; 27(1):12-22.

[Clin Ther. 2005]
» See reviews... | » See all...

Cited by 7 PubMed Central articles

ReviewAcinetobacter baumannii: emergence of a successful pathogen.
Peleg AY, Seifert H, Paterson DL. Clin Microbiol Rev. 2008 Jul; 21(3):538-82.

[Clin Microbiol Rev. 2008]
In vitro activity of tigecycline against gram-positive and gram-negative pathogens as evaluated by broth microdilution and Etest.
Pillar CM, Draghi DC, Dowzicky MJ, Sahm DF. J Clin Microbiol. 2008 Sep; 46(9):2862-7. Epub 2008 Jul 2.

[J Clin Microbiol. 2008]
Hypermucoviscosity as a virulence factor in experimental Klebsiella pneumoniae endophthalmitis.
Wiskur BJ, Hunt JJ, Callegan MC. Invest Ophthalmol Vis Sci. 2008 Nov; 49(11):4931-8. Epub 2008 Jun 27.

[Invest Ophthalmol Vis Sci. 2008]
» See all...

Recent Activity

Clear Turn Off Turn On

Antimicrobial susceptibility among pathogens collected from hospitalized patients in the U...Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial.

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Display Show

Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial.

Related articles

Cited by 7 PubMed Central articles

Recent Activity